.gif)
.gif)
.gif)
.gif)
This is a link
To ensure that resources are accurate and up-to-date, PRIMR has a rigorous process for maintaining excellence including in-house review by a board-certified physician, peer and patient advocate reviews, Institutional Review Board (IRB) in the US and independent ethics committee (IEC) review in the EU, as well as content updates based on protocol changes or study guidelines.
PRIMR incorporates a variety of visual elements and formats beyond just images and diagrams. PRIMR considers factors such as the selection of onscreen text and the simplicity of graphics to appeal to different learning styles. Even color is considered to ensure emphasis on important concepts. The writing of PRIMIR content in itself is meant to replicate how a physician would speak to their patient in clinic, which may or may not include visuals during the visit.
PRIMR’s approach to ensuring low-risk content approval by IRBs involves rigorous processes and adherence to regulatory standards.
With a track record of 100% IRB approval on first submission for our content over 4 years, PRIMR demonstrates its commitment to compliance and quality assurance.
PRIMR employs thorough review processes, collaboration with key opinion leaders in our network, and adherence to industry best practices to achieve consistent approval rates. Other content vendors lack oncology expertise, outsource expert review, slowing down the process, increasing costs and lowering the ultimate quality of the product and impact on patient understanding.
PRIMR ensures effective reach and addresses lopsided demographics in clinical trials through strategic geo-targeted ads and multilingual content creation.
By tailoring content distribution to specific geographic regions and providing multilingual materials, PRIMR aims to enhance trial awareness among diverse populations, thus promoting better representation in clinical trials.
Yes. PRIMR can be implemented at the enterprise level. Pricing and details are custom, up to and including co-branded PRIMR content with access to the PRIMR asset library to use on health system-native websites, social posts and marketing materials. We also offer enterprise licensing for access to PRIMR simply for HIPAA secure point of care distribution of home grown digital patient education content.
At this stage we are handling specific content requests case by case. We usually can accommodate general oncology-related content requests within 2 weeks. Content requests for for a specific drug, device or institution may be fulfilled for a fee.
Yes. Some physicians create their own content and use PRIMR as a HIPAA secure distribution tool at the point of care. PRIMR-hosted content is delivered directly to patients' mobile device - a more engaging process than passively referring patients to static websites.
Yes - all of our content for clinical trials is IRB approved. We guarantee IRB approval and historically have a 100% success rate. Speed of approval wholly depends on IRB. Non-clinical trial (general education) content does not need IRB approval.
Medical information is abundant on the internet. Many patients struggle however to consume content that is both credible and applicable to their condition. When a trusted doctor creates or curates content for patients, they solve both these problems. Industry-produced content often misses the mark - either too general to be helpful, or overly specific, endorsing a certain drug, device or technique. Doctors have a breadth of experience speaking with real patients about their actual concerns. This allows doctors to make content that anticipates common questions and concerns.
For clinical trial recruitment, PRIMR tracks patient engagement data including impressions, views, % viewed and geolocation. We report data out to PIs and sponsors monthly. Our analytics show patients watch PRIMR videos 1.9 times on average, suggesting very high level of engagement.
No. PRIMR supplements the in person encounter with an additional layer of digital patient education that can be consumed asynchronously offline, on demand and shared with friends and family at scale. PRIMR does not replace the work of doctor patient knowledge transfer, it enhances it. Early adopters of PRIMR report improved patient experience. When patients have on demand access to information about treatment details, risks and side effects, there is less burden on them to memorize or transcribe information during the live encounter. PRIMR creates space for patients to be fully present for the precious time they have face to face with their doctors.